// App-Quantinova.ai

622 : Phase I/II Study of Monotherapy with Subcutaneous Injections of Low-Dose Anti-CD20 Veltuzumab in Relapsed Immune Thrombocytopenia

Researchers

Presenter

  • Mansoor N Saleh

Principal Investigators

  • James B. Bussel

  • O George Negrea

  • Heather Horne

  • William Wegener

  • David M Goldenberg

  • Diane L Rossi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Immunomedics, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Immune thrombocytopenia

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Thrombocytopenia

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • Circulating tumor cells

  • Cluster of Differentiation 19

Drug/Treatment

  • HA20

  • Oraprine

  • Veltucyn (IV)

  • Rituximab

  • Danazol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved